2 recruiting, 1 active not recruiting, 1 completed, 1 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Recruiting 2, Active not recruiting 1, Completed 1, Withdrawn 1 |
Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness and Safety of Electrically Powered Orthopedic Exercise Device for Gait Disorders Electrically Powered Orthopedic Exercise Device - Gait Disorders | Phase 4 | Recruiting | Yonsei University | 30 | 2025-04-07 | 2025-08-29 |
| TESTO-TRIAL: Use of Testosterone in Critically Ill Patients Testosterone cypionate (200mg/3ml), Sesame oil (3ml) - Weaning Failure, Muscle Weakness | Phase 4 | Active not recruiting | Leticia Maria Defendi Barboza Marson | 94 | 2024-09-09 | 2024-12-18 |
| DBS and Levodopa for Treating Freezing of Gait in Parkinson's Disease STIM ON plus, MED ON plus - Freezing of Gait, Parkinson Disease | Phase 4 | Recruiting | IRCCS Istituto delle Scienze Neurologiche di Bologna | 20 | 2023-10-10 | 2024-03-18 |
| Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries Sugammadex, Neostigmine - Ambulatory Difficulty | Phase 4 | Withdrawn | Montefiore Medical Center | 2019-06-20 | 2019-11-18 | |
| Impact of tDCS on Locomotion and Equilibrium in Hemiplegic Patients anodal tDCS and sham tDCS stimulations - Gait Disorders | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 27 | 2014-07-10 | 2019-03-13 |
Critical Illness (1) · Muscle Weakness (1) · Parkinson Disease (1) · Stroke (1)
Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Nervous System Diseases (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Basal Ganglia Diseases (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Disease Attributes (1) · Movement Disorders (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1)
Neostigmine (1) · Sesame Oil (1) · Sugammadex (1) · testosterone 17 beta-cypionate (1)
Assistance Publique - Hôpitaux de Paris (1) · IRCCS Istituto delle Scienze Neurologiche di Bologna (1) · Leticia Maria Defendi Barboza Marson (1) · Montefiore Medical Center (1) · Yonsei University (1)
Brazil (1) · France (1) · Italy (1) · South Korea (1)
Curtis Choice, MD (1) · Ilaria Cani (1) · Na Young Kim, MD, PhD (1)
2019 (1)